Hironori Koga

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Cancers

Cancer medicine

Hepatology international

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Hajime Masubuchi, Yasuko Imamura, Takumi Kawaguchi, Hironori Koga
Leucine drives LAT1-related SNAIL upregulation in glucose-starved pancreatic cancer cells. Medical molecular morphology (2024)
Toshimitsu Tanaka, Hironori Koga, Hiroyuki Suzuki, Hideki Iwamoto, Takahiko Sakaue, Atsutaka Masuda, Toru Nakamura, Jun Akiba, Hirohisa Yano, Takuji Torimura, Takumi Kawaguchi
Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells. Hepatology international (2023)
Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Yoichi Yano, Satoru Matsugaki, Etsuko Moriyama, Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. Cancer medicine (2023)
Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Masatoshi Tanaka, Tomotake Shirono, Etsuko Moriyama, Yu Noda, Masahito Nakano, Hideya Suga, Ryoko Kuromatsu, Takuji Torimura, Hironori Koga, Takumi Kawaguchi
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching. International journal of molecular sciences 24 (18) (2023)
Ryoko Kuromatsu, Tatsuya Ide, Shusuke Okamura, Yu Noda, Naoki Kamachi, Masahito Nakano, Tomotake Shirono, Shigeo Shimose, Hideki Iwamoto, Reiichiro Kuwahara, Teruko Arinaga-Hino, Takashi Niizeki, Yuki Zaizen, Hiroshi Takaki, Miki Shirachi, Hironori Koga, Takuji Torimura
Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer. Cancers 14 (9) (2022)
Shigeo Shimose, Atsushi Hiraoka, Andrea Casadei-Gardini, Tsubasa Tsutsumi, Dan Nakano, Hideki Iwamoto, Fujimasa Tada, Margherita Rimini, Masatoshi Tanaka, Takuji Torimura, Hideya Suga, Hideko Ohama, Valentina Burgio, Takashi Niizeki, Etsuko Moriyama, Hiroyuki Suzuki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology (2022)
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, Kazuomi Ueshima, Joji Tani, Teiji Kuzuya, Kazuhiro Kasai, Youhei Kooka, Atsushi Hiraoka, Rie Sugimoto, Takehiro Yonezawa, Satoshi Tanaka, Akihiro Deguchi, Shigeo Shimose, Tomotake Shirono, Miwa Sakai, Hiroyuki Suzuki, Etsuko Moriyama, Hironori Koga, Takuji Torimura, Takumi Kawaguchi, null New Fp Study Group, null Kurume Liver Cancer Study Group Of Japan
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function. Cancers 14 (19) (2022)
Dan Nakano, Takumi Kawaguchi, Tsubasa Tsutsumi, Masako Hayakawa, Sachiyo Yoshio, Hironori Koga, Takuji Torimura
Effects of SGLT2 inhibitor on tumor-releasing chemokines/cytokines in Hep3B and Huh7 cells. JGH open : an open access journal of gastroenterology and hepatology 6 (4) (2022)
Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Etsuko Moriyama, Tomotake Shirono, Yu Noda, Naoki Kamachi, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi
Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study. Cancers 14 (17) (2022)
Tomotake Shirono, Hironori Koga, Takashi Niizeki, Hiroaki Nagamatsu, Hideki Iwamoto, Shigeo Shimose, Masahito Nakano, Shusuke Okamura, Yu Noda, Naoki Kamachi, Ryoko Kuromatsu, Etsuyo Ogo, Takuji Torimura
Usefulness of a novel transarterial chemoinfusion plus external-beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right atrium: Case study. Cancer reports (Hoboken, N.J.) (2021)
Yuki Zaizen, Masahito Nakano, Kazuta Fukumori, Yoichi Yano, Kota Takaki, Takashi Niizeki, Kotaro Kuwaki, Masaru Fukahori, Takahiko Sakaue, Sohei Yoshimura, Mika Nakazaki, Ryoko Kuromatsu, Shusuke Okamura, Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Yu Noda, Naoki Kamachi, Hironori Koga, Takuji Torimura
Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Cancers 13 (21) (2021)
Hideki Iwamoto, Shigeo Shimose, Yu Noda, Tomotake Shirono, Takashi Niizeki, Masahito Nakano, Shusuke Okamura, Naoki Kamachi, Hiroyuki Suzuki, Miwa Sakai, Akira Kajiwara, Satoshi Itano, Masatoshi Tanaka, Taizo Yamaguchi, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura, null On Behalf Of The Kurume Liver Cancer Study Group Of Japan
Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice. Cancers 13 (11) (2021)
Takashi Niizeki, Hideki Iwamoto, Tomotake Shirono, Shigeo Shimose, Masahito Nakano, Shusuke Okamura, Yu Noda, Naoki Kamachi, Hiroyuki Suzuki, Miwa Sakai, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura
Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion. Cancers 13 (17) (2021)
Naoki Kamachi, Masahito Nakano, Shusuke Okamura, Takashi Niizeki, Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Yu Noda, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura
Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast-enhanced ultrasound. Cancer reports (Hoboken, N.J.) (2021)
Shigeo Shimose, Atsushi Hiraoka, Masahito Nakano, Hideki Iwamoto, Masatoshi Tanaka, Takaaki Tanaka, Kazunori Noguchi, Hajime Aino, Kei Ogata, Masahiko Kajiwara, Satoshi Itano, Yoshinori Yokokura, Taizo Yamaguchi, Hiroshi Kawano, Norito Matsukuma, Hideya Suga, Takashi Niizeki, Tomotake Shirono, Yu Noda, Naoki Kamachi, Shusuke Okamura, Takumi Kawaguchi, Hironori Koga, Takuji Torimura
First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study. Cancer medicine 10 (23) (2021)
Tatsuya Ide, Hironori Koga, Masahito Nakano, Satoru Hashimoto, Hiroshi Yatsuhashi, Nobito Higuchi, Makoto Nakamuta, Satoshi Oeda, Yuichiro Eguchi, Satoshi Shakado, Shotaro Sakisaka, Yoko Yoshimaru, Yutaka Sasaki, Yuichi Honma, Masaru Harada, Masataka Seike, Tatsuji Maeshiro, Satoshi Miuma, Kazuhiko Nakao, Seiichi Mawatari, Akio Ido, Kenji Nagata, Shuichi Matsumoto, Yuko Takami, Tetsuo Sohda, Tatsuyuki Kakuma, Takuji Torimura
Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study. Hepatology international 13 (3) (2019)
Yu Noda, Takumi Kawaguchi, Masaaki Korenaga, Sachiyo Yoshio, Sho Komukai, Masahito Nakano, Takashi Niizeki, Hironori Koga, Atsushi Kawaguchi, Tatsuya Kanto, Takuji Torimura
High serum interleukin-34 level is a predictor of poor prognosis in patients with non-viral hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 49 (9) (2019)
Masahito Nakano, Hironori Koga, Tatsuya Ide, Ryoko Kuromatsu, Satoru Hashimoto, Hiroshi Yatsuhashi, Masataka Seike, Nobito Higuchi, Makoto Nakamuta, Satoshi Shakado, Shotaro Sakisaka, Satoshi Miuma, Kazuhiko Nakao, Yoko Yoshimaru, Yutaka Sasaki, Satoshi Oeda, Yuichiro Eguchi, Yuichi Honma, Masaru Harada, Kenji Nagata, Seiichi Mawatari, Akio Ido, Tatsuji Maeshiro, Shuichi Matsumoto, Yuko Takami, Tetsuo Sohda, Takuji Torimura
Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study. Cancer medicine 8 (5) (2019)
Fumitaka Wada, Hironori Koga, Jun Akiba, Takashi Niizeki, Hideki Iwamoto, Yu Ikezono, Toru Nakamura, Mitsuhiko Abe, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Tatsuyuki Kakuma, Hirohisa Yano, Takuji Torimura
High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine. Cancer science 109 (9) (2018)

Hironori Koga.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hironori Koga